Revelation Biosciences, Inc.
corporate_fare Company Profile
Revelation Biosciences, Inc. (NASDAQ:REVB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for REVB at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Revelation Biosciences Registers 4.27M Shares for Resale, Signaling Massive Potential Dilution
- Revelation Biosciences Secures $7.3M from Warrant Exercises, Issues New Warrants
- Revelation Biosciences Secures FDA Agreement for Gemini AKI Approval Pathway
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$8.91M
Diluted EPS
-$23.95
Op. Cash Flow
-$8.27M
Operating Income
-$9.07M
Cash & Equivalents
$10.7M
Debt / Equity
0.00×
Shares Outstanding
1.58M sh
Source: 10-K · filed 2026-02-26 · accession 0001193125-26-076552
show_chartPrice Chart
Loading chart...
feed REVB - Filings & News (Page 2)
REVB
Jan 30, 2026, 4:05 PM EST
Price at Filing:
$2.03
Real-time Price:
$3.55
Change:
Reverse Stock Split
Market Cap:
$2.392M
REVB
Jan 28, 2026, 6:46 PM EST
Price at Filing:
$2.03
Real-time Price:
$3.55
Change:
Reverse Stock Split
Market Cap:
$2.392M
REVB
Jan 21, 2026, 7:01 PM EST
Price at Filing:
$0.8331
Real-time Price:
$3.55
Change:
Reverse Stock Split
Market Cap:
$2.392M